Search - tctmd.com

Displaying 21 - 33 of 33

Sort: Relevancy | Date

Presentation TCT 2017

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Presenter: Nick Curzen, Rod H. Stables

October 31, 2017

Presentation TCT 2017

Case Presentation: Moderate-Severe Degenerative Mitral Regurgitation in a 70-Year-Old Female With a Moderately Dilated LV and LVEF of 40%

Presenter: Habib Gamra, Mohamed Ahmed Sobhy, Mahmoud Soliman

October 29, 2017

Presentation

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Presenter: V. Dayan

December 06, 2015

Presentation TCT 2015

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options Focused Commentary

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options

Presenter: Martin B. Leon, Mark Reisman, Chet Rihal, Olaf Franzen

October 15, 2015

Presentation TCT 2015

TCT 9: Early PICSO Preserves LVEF in Porcine Acute Myocardial Infarction

Presenter: Eric Boersma, Richard Smalling, Roger Kessels

October 13, 2015

Presentation TCT 2015

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy

October 12, 2015

Presentation

Comparison of Outcomes of Patients With LVEF Less Than or Equal to 30% vs Greater Than 30% Having TAVR

Presenter: Ulrich Schaefer

January 06, 2015

Presentation TCT 2014

Patient #2: How Can I Treat This 52 Year Old Patient with LF, LG, and Critical AS with Severely Depressed LVEF?

Presenter: Marco A. Alcocer-Gamba, Sunil V. Rao, Ramiro Trillo, Juan Alberto Quintanilla Gutierrez

September 13, 2014

Presentation

Impact of CAD on LVEF Recovery Following TAVI

Presenter: X. Freixa

September 10, 2014

Presentation Cell Therapy 2014

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Presenter: Micha? Tendera

January 22, 2014

Presentation

Long-term Analysis of LVEF in Patients with Stable Multivessel Coronary Disease Undergoing Medicine, Angioplasty, or Surgery

Presenter: Cibele Larrosa Garzillo

July 09, 2013

Presentation

Effect of Shock Wave-Facilitated Intracoronary Cell Therapy on LVEF in Pts with Chronic Heart Failure

Presenter: B. Assmus

April 16, 2013

Advertisement

Case #2 Introduction: 85-Year-Old Patient With Previous Stents and Severe Aortic Stenosis, Reduced LVEF, Chronic Anemia, and Mild Renal Impairment Develops Atrial Fibrillation After TAVR

Case Presentation: Moderate-Severe Degenerative Mitral Regurgitation in a 70-Year-Old Female With a Moderately Dilated LV and LVEF of 40%

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options Focused Commentary

Severe Functional MR + Symptoms With Slightly Reduced LVEF (45%) and Moderate Surgical Risk: Treatment Options

TCT 9: Early PICSO Preserves LVEF in Porcine Acute Myocardial Infarction

Is Hemodynamic Collapse Due to Increased Afterload After MV Replacement in Severe MR With Reduced LVEF a Real Phenomenon?

Comparison of Outcomes of Patients With LVEF Less Than or Equal to 30% vs Greater Than 30% Having TAVR

Patient #2: How Can I Treat This 52 Year Old Patient with LF, LG, and Critical AS with Severely Depressed LVEF?

Impact of CAD on LVEF Recovery Following TAVI

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Long-term Analysis of LVEF in Patients with Stable Multivessel Coronary Disease Undergoing Medicine, Angioplasty, or Surgery

Effect of Shock Wave-Facilitated Intracoronary Cell Therapy on LVEF in Pts with Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content